[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[H.J. Res. 58 Introduced in House (IH)]
<DOC>
119th CONGRESS
1st Session
H. J. RES. 58
Providing for congressional disapproval under chapter 8 of title 5,
United States Code, of the rule submitted by the Centers for Medicare &
Medicaid Services relating to ``Medicare Program; Calendar Year (CY)
2025 Home Health Prospective Payment System (HH PPS) Rate Update; HH
Quality Reporting Program Requirements; HH Value-Based Purchasing
Expanded Model Requirements; Home Intravenous Immune Globulin (IVIG)
Items and Services Rate Update; and Other Medicare Policies''.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
February 12, 2025
Mr. Clyde submitted the following joint resolution; which was referred
to the Committee on Ways and Means, and in addition to the Committee on
Energy and Commerce, for a period to be subsequently determined by the
Speaker, in each case for consideration of such provisions as fall
within the jurisdiction of the committee concerned
_______________________________________________________________________
JOINT RESOLUTION
Providing for congressional disapproval under chapter 8 of title 5,
United States Code, of the rule submitted by the Centers for Medicare &
Medicaid Services relating to ``Medicare Program; Calendar Year (CY)
2025 Home Health Prospective Payment System (HH PPS) Rate Update; HH
Quality Reporting Program Requirements; HH Value-Based Purchasing
Expanded Model Requirements; Home Intravenous Immune Globulin (IVIG)
Items and Services Rate Update; and Other Medicare Policies''.
Resolved by the Senate and House of Representatives of the United
States of America in Congress assembled, That Congress disapproves the
rule submitted by the Centers for Medicare & Medicaid Services relating
to ``Medicare Program; Calendar Year (CY) 2025 Home Health Prospective
Payment System (HH PPS) Rate Update; HH Quality Reporting Program
Requirements; HH Value-Based Purchasing Expanded Model Requirements;
Home Intravenous Immune Globulin (IVIG) Items and Services Rate Update;
and Other Medicare Policies'' (89 Fed. Reg. 88354 (November 7, 2024)),
and such rule shall have no force or effect.
<all>